Deep Track Capital, LP

Deep Track Capital, LP reported 74 holdings worth US$6.14B as of Sep 30, 2026 (Form 13F)

As of Sep 30, 2026 · Filed Nov 16, 2026

Deep Track Capital, LP reported 74 holdings worth US$6.14B as of Sep 30, 2026. Largest: Guardant Health, Inc., BioMarin Pharmaceutical Inc. and Immunovant, Inc. Filed Nov 16, 2026 (Form 13F).

Holdings
74
Value as reported
US$6.14B

The filing in full

CompanySharesValue as reported% of portfolio
Guardant Health, Inc.2.81MUS$500M8.2%
BioMarin Pharmaceutical Inc.6.37MUS$382M6.2%
Immunovant, Inc.9.16MUS$309M5.0%
Tarsus Pharmaceuticals, Inc.3.81MUS$299M4.9%
Veradermics, Incorporated1.9MUS$230M3.8%
Vera Therapeutics, Inc.7MUS$226M3.7%
Vaxcyte, Inc.3.51MUS$200M3.3%
Ocular Therapeutix, Inc.21.9MUS$168M2.7%
United Therapeutics Corporation300KUS$163M2.6%
Structure Therapeutics, Inc.5MUS$156M2.5%
GRAIL, Inc.1.1MUS$155M2.5%
Insmed Incorporated1.35MUS$154M2.5%
COMPASS Pathways Plc12.2MUS$151M2.5%
Genmab A/S4.18MUS$149M2.4%
Axsome Therapeutics, Inc.800KUS$148M2.4%
Nurix Therapeutics, Inc.6MUS$142M2.3%
LB Pharmaceuticals Inc3.35MUS$129M2.1%
Tango Therapeutics, Inc.4.5MUS$112M1.8%
Maze Therapeutics, Inc.4.08MUS$111M1.8%
Hemab Therapeutics Holdings, Inc.3.59MUS$111M1.8%
Oruka Therapeutics, Inc.1.07MUS$89.1M1.5%
GeneDx Holdings Corp.1.2MUS$86.8M1.4%
Cogent Biosciences, Inc.2.5MUS$80M1.3%
Bicara Therapeutics Inc.4.1MUS$76.3M1.2%
Latigo Biotherapeutics, Inc.4.41MUS$73.6M1.2%
Celldex Therapeutics, Inc.2.13MUS$68.9M1.1%
BridgeBio Pharma, Inc.886KUS$58.3M0.95%
Avalo Therapeutics, Inc.3.61MUS$55.3M0.90%
Alumis Inc.7.47MUS$55.2M0.90%
Altimmune, Inc.19.3MUS$55.1M0.90%
Attovia Therapeutics, Inc.3.21MUS$55M0.90%
BillionToOne, Inc.500KUS$53.2M0.87%
Aclaris Therapeutics, Inc.9.35MUS$49.2M0.80%
CorMedix Inc.6.27MUS$48.3M0.79%
Edgewise Therapeutics, Inc.1.15MUS$46.6M0.76%
Verastem, Inc.5.74MUS$46.2M0.75%
Definium Therapeutics, Inc.1MUS$38.1M0.62%
Generate Biomedicines, Inc.2.51MUS$37.7M0.61%
MBX Biosciences, Inc.640KUS$37.5M0.61%
ANI Pharmaceuticals, Inc.500KUS$36.3M0.59%
Viridian Therapeutics, Inc.1.71MUS$35.2M0.57%
Harrow, Inc.1.07MUS$32.9M0.54%
Obsidian Therapeutics, Inc.2.12MUS$29.1M0.47%
Corvus Pharmaceuticals, Inc.2.49MUS$28.7M0.47%
Neurocrine Biosciences, Inc.200KUS$28.4M0.46%
Solid Biosciences Inc.3.57MUS$25.8M0.42%
Shattuck Labs, Inc.3.71MUS$25.3M0.41%
Beam Therapeutics Inc.1MUS$24.4M0.40%
MannKind Corporation5.03MUS$19.6M0.32%
Xenon Pharmaceuticals Inc.500KUS$18.6M0.30%
Olema Pharmaceuticals, Inc.2.11MUS$18.2M0.30%
Nektar Therapeutics300KUS$18.2M0.30%
Design Therapeutics, Inc.1.32MUS$16.6M0.27%
Century Therapeutics, Inc.9.46MUS$16.2M0.26%
Xencor, Inc.540KUS$13.5M0.22%
MapLight Therapeutics, Inc.1.32MUS$13.4M0.22%
Enanta Pharmaceuticals, Inc.1MUS$13.2M0.21%
X4 Pharmaceuticals, Inc.4.5MUS$13.1M0.21%
Kardigan, Inc.600KUS$8.85M0.14%
ProMIS Neurosciences Inc.740KUS$8.03M0.13%
RxSight, Inc.1.23MUS$6.03M0.10%
Rainier Acquisition Corporation500KUS$5.1M0.08%
JATT III Acquisition Corp450KUS$4.96M0.08%
Research Alliance Corporation IV400KUS$4.63M0.08%
TCGX Acquisition Corp.300KUS$3.75M0.06%
Aligos Therapeutics, Inc.444KUS$2.5M0.04%
Context Therapeutics Inc.7.42MUS$2.23M0.04%
Alnylam Pharmaceuticals, Inc.0US$00.00%
AtaiBeckley Inc.0US$00.00%
Cytokinetics, Incorporated0US$00.00%
Dyne Therapeutics, Inc.0US$00.00%
Enliven Therapeutics, Inc.0US$00.00%
Immix Biopharma, Inc.0US$00.00%
Inventiva SA0US$00.00%
Ionis Pharmaceuticals, Inc.0US$00.00%
Kailera Therapeutics, Inc.0US$00.00%
Kura Oncology, Inc.0US$00.00%
Nuvalent, Inc.0US$00.00%
Personalis, Inc.0US$00.00%

Source

Download original · View original at SEC

Related